BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2016

Jan 21, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2016-01-20

Reporting Person: Stonehouse Jon P (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-20	Common Stock	M	24096	$4.15	Acquired	676326	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-20	Emp. Stock Option (Right to Buy)	$4.15	M	24096	Disposed	2021-03-01	Common Stock (24096)	Direct